Search results

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics. Lung tumors are often difficult to remove using current surgical techniques due to their location in

https://www.medicine.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2025-09-29

Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an imaging technique that can more accurately detect and track the development of Pa

https://www.medicine.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2025-09-29

Prof. Johan Jakobsson and Assoc. Prof. Agnete Kirkeby from Lund Stem Cell Center and University of Copenhagen, along with co-applicants Prof. Roger Barker from Cambridge, UK and Assoc. Prof. Molly Hammell from Cold Spring Harbour Laboratory, US, have been awarded a prestigious grant from the Aligning Science Across Parkinson’s initiative. Using this funding they will investigate the role transposa

https://www.medicine.lu.se/article/researchers-investigate-role-transposable-elements-neuroinflammation-and-parkinsons-disease - 2025-09-29

The University Board has today decided to recommend the dean of the Faculty of Medicine, Erik Renström, as the new vice-chancellor of Lund University for the term of office 2021 to 2026. "This is a big step. I am humble and it is with deep respect I am looking forward to this task", comments Erik Renström.He is also highlighting that the definitive decision from the Swedish Government is yet not t

https://www.medicine.lu.se/article/erik-renstrom-proposed-new-vice-chancellor - 2025-09-29

Johan Richter's research has resulted in the successful development of gene therapy for the hereditary disease malignant infantile osteopetrosis. For the past few years, the research group has established a collaboration with an American biotech company and all the permits needed to start a clinical trial have now been obtained. Every year in Sweden a child is born with the unusual skeletal diseas

https://www.medicine.lu.se/article/successful-biotech-collaboration-brings-gene-therapy-project-clinic - 2025-09-29

Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient will respond to metformin treat

https://www.medicine.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-09-29

A large proportion of our elite athletes are suffering psychological distress during the COVID-19 pandemic, with more women than men reporting adverse reactions. This is demonstrated by the study Psychological Distress and Problem Gambling in Elite Athletes during COVID-19 Restrictions: A Web Survey in Top Leagues of Three Sports during the Pandemic, published in the International Journal of Envir

https://www.medicine.lu.se/article/many-elite-athletes-feeling-psychological-distress-during-pandemic - 2025-09-29

Lund University researchers have developed an analytical model that can effectively detect and identify gene mutations in breast tumours. In the study, which is the largest of its kind anywhere in the world, they are now reporting results from 3,200 breast cancer patients. To assist them, they have utilised a technique known as RNA sequencing, a sensitive and precise tool that, while it is slowly

https://www.medicine.lu.se/article/new-analytical-method-benefits-breast-cancer-patients - 2025-09-29

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 20 children in Sweden are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands.

https://www.medicine.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2025-09-29

Agnete Kirkeby is working to repair the brain with stem cells. “The goal of our research is to understand how the human brain is formed and how it functions. And how we can repair it by generating new cells in the lab.” Agnete Kirkeby is one of the reserchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center.WCMM at

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-agnete-kirkeby - 2025-09-29

Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study. Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million people have the disease globally.“Current treatment methods are unfor

https://www.medicine.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2025-09-29

Niklas Mattsson-Carlgren is searching for underlying causes for Alzheimer’s Disease. “I am motivated by the possibility that my work may make difference for patients with Alzheimer’s Disease.” Niklas Mattsson-Carlgren is one of the reserchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center.WCMM at Lund University

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-niklas-mattsson-carlgren - 2025-09-29

Nicholas Leigh is studying how other organisms have solved biological problems “The idea is that by understanding how other species are able to, for instance, regenerate a limb, we could help promote regeneration in humans.” Nicholas Leigh is one of the researchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center.

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-nicholas-leigh - 2025-09-29

In a collaborative study, researchers from Lund Stem Cell Center and University College London have developed a novel method of isolating ‘young’ stem cells still present in old mice. They show that activity of mitochondria, the power generators of the cell, is a stronger indicator of stem cell fitness than age and is a potential therapeutic target for the treatment of age associated disease. The

https://www.medicine.lu.se/article/novel-approach-identifies-young-stem-cells-old-mice - 2025-09-29

Researchers at Lund University in Sweden studied self-grooming rats in order to better understand how the brain chooses what comes next in a sequence of actions. The study shows that when they switch from one action to the next in the grooming chain, the signalling in different parts of the brain changes. The results, published recently in Science Advances, increase understanding of which processe

https://www.medicine.lu.se/article/self-grooming-rats-offered-clues-how-brain-chooses-behaviour - 2025-09-29

Paul Bourgine is studying skeletal tissue regeneration. “We study how human bones form, regenerate and how they function as a blood production center and use this knowledge for the design of specific regenerative therapies” Paul Bourgine is one of the researchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center. WC

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-paul-bourgine - 2025-09-29

Filipe Pereira explore if reprogramming cells can pave the way for new cancer treatment. “We explore cell reprogramming strategies that can be applied for the treatment of human diseases and benefit of our whole society". Filipe Pereira is one of the researchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center. WCM

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-filipe-pereira - 2025-09-29

Stefan Karlsson has been active as a researcher at Lund University for 25 years and during that time has received many major grants and awards. However, never a gold medal. - It feels like a very great honor because the medal is only awarded every nine years for medical research efforts, says Stefan KarlssonThe Royal Physiographic Society will be awarding the commemorative medal to Stefan Karlsson

https://www.medicine.lu.se/article/gold-medal-stefan-karlsson - 2025-09-29

In October, Predrag Bakic received a research grant from the Swedish Breast Cancer Association for 600 000 SEK. His research focuses on the evaluation of a novel clinical imaging system for early breast cancer screening, which combines X-ray and mechanical imaging of the breast. Predrag Bakic is a visiting researcher in diagnostic radiology at Lund University, supported by a Marie Curie Fellowship

https://www.medicine.lu.se/article/grants-swedish-breast-cancer-association-breast-cancer-imaging-research - 2025-09-29

Iben Lundgaard is studying the cleaning system of the brain. “Our goal is to discover a mechanism that can be targeted so we can achieve effective brain cleaning even in old age.” Iben Lundgaard is one of the researchers at Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU). This autumn, every week, we present a fellow at the center. WCMM at Lund University is a research centre

https://www.medicine.lu.se/article/meet-weeks-wallenberg-researcher-iben-lundgaard - 2025-09-29